Tapewire

Nasdaq · USD

CHRS

Coherus Oncology, Inc.

Export transactions ↓
Tapewire entity
6276
SEC CIK
0001512762
Parsed reports
296

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 10, 2020 Filed Jan 14, 2020 22:48 UTC
Anicetti Vincent RChief Operating Officer
Tax withholdingCommon Stock, $0.0001 par value 7,146 $17.73 $126,698.58
Disclosure

SEC source: 0001567619-20-001038 · doc1.xml · nonDerivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,746

Read SEC document
January 10, 2020 Filed Jan 14, 2020 22:48 UTC
Anicetti Vincent RChief Operating Officer
GrantCommon Stock, $0.0001 par value 19,566 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-001038 · doc1.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,892

Read SEC document
January 10, 2020 Filed Jan 14, 2020 22:52 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $17.73 $0.00
Disclosure

SEC source: 0001567619-20-001043 · doc1.xml · derivative · entry 1

Richards Christos · CIK 0001622055 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-01-10

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
January 09, 2020 Filed Jan 13, 2020 16:45 UTC
HEALY JAMESDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $10.05 $0.00
Disclosure

SEC source: 0001567619-20-000939 · doc1.xml · derivative · entry 6

HEALY JAMES · CIK 0001245624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2028-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The underlying shares subject to the option vest are fully vested and exercisable.

Read SEC document
January 09, 2020 Filed Jan 13, 2020 16:45 UTC
HEALY JAMESDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 29,994 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001567619-20-000939 · doc1.xml · derivative · entry 5

HEALY JAMES · CIK 0001245624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,994 shares

Expires 2024-04-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The underlying shares subject to the option vest are fully vested and exercisable.

Read SEC document
January 09, 2020 Filed Jan 13, 2020 16:45 UTC
HEALY JAMESDirector
Exercise / conversionCommon Stock, $0.0001 par value 20,000 $10.05 $201,000.00
Disclosure

SEC source: 0001567619-20-000939 · doc1.xml · nonDerivative · entry 2

HEALY JAMES · CIK 0001245624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,086

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 09, 2020 Filed Jan 13, 2020 16:45 UTC
HEALY JAMESDirector
Exercise / conversionCommon Stock, $0.0001 par value 29,994 $1.67 $50,000.00
Disclosure

SEC source: 0001567619-20-000939 · doc1.xml · nonDerivative · entry 1

HEALY JAMES · CIK 0001245624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,086

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:28 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001567619-19-023319 · doc1.xml · derivative · entry 3

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,988

Underlying: Common Stock · 2,500 shares

Expires 2024-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:28 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock, $0.0001 par value 2,500 $18.69 $46,725.00
Disclosure

SEC source: 0001567619-19-023319 · doc1.xml · nonDerivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,326

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.

F1 · balance_after: Includes 16 shares acquired on November 15, 2019, pursuant to Issuer's employee stock purchase plan.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:28 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock, $0.0001 par value 2,500 $2.50 $6,251.25
Disclosure

SEC source: 0001567619-19-023319 · doc1.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,826

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 16 shares acquired on November 15, 2019, pursuant to Issuer's employee stock purchase plan.

Read SEC document
November 21, 2019 Filed Nov 25, 2019 21:03 UTC
Lanfear Dennis MDirector · President & CEO
SaleCommon Stock, $0.0001 par value 12,500 $18.56 $231,960.00
Disclosure

SEC source: 0001567619-19-022189 · doc1.xml · nonDerivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 446,684

F1 · price: The transaction was executed in multiple trades in prices ranging from $18.39 to $18.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.

Read SEC document
November 20, 2019 Filed Nov 22, 2019 23:56 UTC
Lanfear Dennis MDirector · President & CEO
SaleCommon Stock, $0.0001 par value 825,000 $18.00 $14,850,000.00
Disclosure

SEC source: 0001567619-19-022127 · doc1.xml · nonDerivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 459,184

F1 · kind: The Reporting Person is selling the shares to an existing stockholder, V-Sciences Investments Pte Ltd., in a private transaction at a purchase price of $18 per share. The sale will be effected in two tranches as follows: (i) 470,000 shares will be sold on November 22, 2019 and (ii) 355,000 shares will be sold on the third business day following the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976.

F2 · ownership.nature: These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.

Read SEC document
November 20, 2019 Filed Nov 22, 2019 16:09 UTC
Viret Jean-FredericChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,159 $0.00 Strike: $10.05 $0.00
Disclosure

SEC source: 0001567619-19-022077 · doc1.xml · derivative · entry 3

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,046

Underlying: Common Stock · 3,159 shares

Expires 2028-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
November 20, 2019 Filed Nov 22, 2019 16:09 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock, $0.0001 par value 3,159 $19.59 $61,871.86
Disclosure

SEC source: 0001567619-19-022077 · doc1.xml · nonDerivative · entry 2

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,303

F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $19.085 to $19.98, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 20, 2019 Filed Nov 22, 2019 16:09 UTC
Viret Jean-FredericChief Financial Officer
Exercise / conversionCommon Stock, $0.0001 par value 3,159 $10.05 $31,747.95
Disclosure

SEC source: 0001567619-19-022077 · doc1.xml · nonDerivative · entry 1

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,462

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 16:22 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock, $0.0001 par value 3,112 $18.88 $58,757.36
Disclosure

SEC source: 0001567619-19-021956 · doc1.xml · nonDerivative · entry 1

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,303

F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $18.74 to $19.065, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 30 shares acquired on November 15, 2019 pursuant to Issuer's employee stock purchase plan.

Read SEC document
November 14, 2019 Filed Nov 18, 2019 21:10 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0001567619-19-021759 · doc1.xml · derivative · entry 3

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,488

Underlying: Common Stock · 2,500 shares

Expires 2024-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
November 14, 2019 Filed Nov 18, 2019 21:10 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock, $0.0001 par value 2,500 $19.26 $48,150.00
Disclosure

SEC source: 0001567619-19-021759 · doc1.xml · nonDerivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,310

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.

Read SEC document
November 14, 2019 Filed Nov 18, 2019 21:10 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock, $0.0001 par value 2,500 $2.50 $6,251.25
Disclosure

SEC source: 0001567619-19-021759 · doc1.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,810

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 18, 2019 Filed Oct 22, 2019 16:06 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock, $0.0001 par value 1,388 $19.02 $26,399.76
Disclosure

SEC source: 0000899243-19-025822 · doc4.xml · nonDerivative · entry 1

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,385

F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.

Read SEC document
October 16, 2019 Filed Oct 18, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,159 $0.00 Strike: $10.05 $0.00
Disclosure

SEC source: 0000899243-19-025758 · doc4.xml · derivative · entry 3

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,205

Underlying: Common Stock · 3,159 shares

Expires 2028-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
October 16, 2019 Filed Oct 18, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock, $0.0001 par value 3,159 $19.00 $60,021.00
Disclosure

SEC source: 0000899243-19-025758 · doc4.xml · nonDerivative · entry 2

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,773

F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.

Read SEC document
October 16, 2019 Filed Oct 18, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
Exercise / conversionCommon Stock, $0.0001 par value 3,159 $10.05 $31,747.95
Disclosure

SEC source: 0000899243-19-025758 · doc4.xml · nonDerivative · entry 1

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,932

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 20:08 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0000899243-19-025608 · doc4.xml · derivative · entry 3

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,988

Underlying: Common Stock · 2,500 shares

Expires 2024-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 20:08 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock, $0.0001 par value 2,500 $18.40 $46,000.00
Disclosure

SEC source: 0000899243-19-025608 · doc4.xml · nonDerivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,310

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 20:08 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock, $0.0001 par value 2,500 $2.50 $6,251.25
Disclosure

SEC source: 0000899243-19-025608 · doc4.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,810

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 23, 2019 Filed Sep 25, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock, $0.0001 par value 740 $21.78 $16,117.20
Disclosure

SEC source: 0000899243-19-024242 · doc4.xml · nonDerivative · entry 1

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,773

F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.

Read SEC document
September 18, 2019 Filed Sep 20, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,159 $0.00 Strike: $10.05 $0.00
Disclosure

SEC source: 0000899243-19-023989 · doc4.xml · derivative · entry 3

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,364

Underlying: Common Stock · 3,159 shares

Expires 2028-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
September 18, 2019 Filed Sep 20, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock, $0.0001 par value 3,159 $20.44 $64,559.85
Disclosure

SEC source: 0000899243-19-023989 · doc4.xml · nonDerivative · entry 2

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,513

F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $19.94 to $20.725, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 18, 2019 Filed Sep 20, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
Exercise / conversionCommon Stock, $0.0001 par value 3,159 $10.05 $31,747.95
Disclosure

SEC source: 0000899243-19-023989 · doc4.xml · nonDerivative · entry 1

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,672

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2019 Filed Sep 18, 2019 20:05 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0000899243-19-023816 · doc4.xml · derivative · entry 3

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,488

Underlying: Common Stock · 2,500 shares

Expires 2024-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
September 16, 2019 Filed Sep 18, 2019 20:05 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock, $0.0001 par value 2,500 $20.03 $50,075.00
Disclosure

SEC source: 0000899243-19-023816 · doc4.xml · nonDerivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,310

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.

Read SEC document
September 16, 2019 Filed Sep 18, 2019 20:05 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock, $0.0001 par value 2,500 $2.50 $6,251.25
Disclosure

SEC source: 0000899243-19-023816 · doc4.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,810

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 21, 2019 Filed Aug 23, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,318 $0.00 Strike: $10.05 $0.00
Disclosure

SEC source: 0000899243-19-022360 · doc4.xml · derivative · entry 4

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,523

Underlying: Common Stock · 6,318 shares

Expires 2028-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
August 21, 2019 Filed Aug 23, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock, $0.0001 par value 6,058 $21.75 $131,765.74
Disclosure

SEC source: 0000899243-19-022360 · doc4.xml · nonDerivative · entry 3

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,513

F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $21.35 to $22.28, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 21, 2019 Filed Aug 23, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock, $0.0001 par value 260 $20.73 $5,388.68
Disclosure

SEC source: 0000899243-19-022360 · doc4.xml · nonDerivative · entry 2

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,571

F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $20.32 to $21.32, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 21, 2019 Filed Aug 23, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
Exercise / conversionCommon Stock, $0.0001 par value 6,318 $10.05 $63,495.90
Disclosure

SEC source: 0000899243-19-022360 · doc4.xml · nonDerivative · entry 1

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,831

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 19, 2019 Filed Aug 21, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock, $0.0001 par value 3,000 $19.04 $57,120.00
Disclosure

SEC source: 0000899243-19-022200 · doc4.xml · nonDerivative · entry 1

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,513

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.

Read SEC document
August 14, 2019 Filed Aug 16, 2019 20:07 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0000899243-19-021944 · doc4.xml · derivative · entry 3

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,988

Underlying: Common Stock · 2,500 shares

Expires 2024-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
August 14, 2019 Filed Aug 16, 2019 20:07 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock, $0.0001 par value 2,500 $19.00 $47,500.00
Disclosure

SEC source: 0000899243-19-021944 · doc4.xml · nonDerivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,310

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.

Read SEC document
August 14, 2019 Filed Aug 16, 2019 20:07 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock, $0.0001 par value 2,500 $2.50 $6,251.25
Disclosure

SEC source: 0000899243-19-021944 · doc4.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,810

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 15, 2019 Filed Jul 17, 2019 20:05 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0000899243-19-019764 · doc4.xml · derivative · entry 3

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,488

Underlying: Common Stock · 2,500 shares

Expires 2024-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the shares underlying this option are vested and exercisable as of the date hereof.

Read SEC document
July 15, 2019 Filed Jul 17, 2019 20:05 UTC
Anicetti Vincent RChief Operating Officer
SaleCommon Stock, $0.0001 par value 2,500 $19.20 $48,000.00
Disclosure

SEC source: 0000899243-19-019764 · doc4.xml · nonDerivative · entry 2

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,310

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.

F1 · balance_after: Includes 2,015 shares acquired on May 15, 2019, pursuant to Issuer's employee stock purchase plan.

Read SEC document
July 15, 2019 Filed Jul 17, 2019 20:05 UTC
Anicetti Vincent RChief Operating Officer
Exercise / conversionCommon Stock, $0.0001 par value 2,500 $2.50 $6,251.25
Disclosure

SEC source: 0000899243-19-019764 · doc4.xml · nonDerivative · entry 1

Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,810

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 2,015 shares acquired on May 15, 2019, pursuant to Issuer's employee stock purchase plan.

Read SEC document
July 02, 2019 Filed Jul 2, 2019 18:57 UTC
HEALY JAMESDirector
SaleCommon Stock, $0.0001 par value 160,000 $22.61 $3,617,600.00
Disclosure

SEC source: 0001144204-19-033657 · tv524689_4.xml · nonDerivative · entry 2

HEALY JAMES · CIK 0001245624 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,933,221

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Venture Partners VII, L.P. on August 23, 2017.

F3 · ownership.nature: The Reporting Person is one of the managing members of the general partner of Sofinnova Venture Partners VII, L.P. that directly holds the reported securities, and as such, may be deemed to share voting and investment power with respect to such securities. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his proportionate pecuniary interest in Sofinnova Ventures Partners VII, L.P.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 18:57 UTC
HEALY JAMESDirector
SaleCommon Stock, $0.0001 par value 200,000 $22.05 $4,410,000.00
Disclosure

SEC source: 0001144204-19-033657 · tv524689_4.xml · nonDerivative · entry 1

HEALY JAMES · CIK 0001245624 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,093,221

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Venture Partners VII, L.P. on August 23, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.17, inclusive. The reporting person undertakes to provide to Coherus BioSciences, Inc., any security holder of Coherus BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: The Reporting Person is one of the managing members of the general partner of Sofinnova Venture Partners VII, L.P. that directly holds the reported securities, and as such, may be deemed to share voting and investment power with respect to such securities. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his proportionate pecuniary interest in Sofinnova Ventures Partners VII, L.P.

Read SEC document
June 20, 2019 Filed Jun 24, 2019 18:30 UTC
HEALY JAMESDirector
SaleCommon Stock, $0.0001 par value 317,130 $21.37 $6,777,068.10
Disclosure

SEC source: 0001144204-19-032103 · tv524060_form4.xml · nonDerivative · entry 1

HEALY JAMES · CIK 0001245624 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,293,221

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Venture Partners VII, L.P. on August 23, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.64, inclusive. The reporting person undertakes to provide to Coherus BioSciences, Inc., any security holder of Coherus BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4

F3 · ownership.nature: The Reporting Person is one of the managing members of the general partner of Sofinnova Venture Partners VII, L.P. that directly holds the reported securities, and as such, may be deemed to share voting and investment power with respect to such securities. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his proportionate pecuniary interest in Sofinnova Ventures Partners VII, L.P.

Read SEC document
June 19, 2019 Filed Jun 20, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,159 $0.00 Strike: $10.05 $0.00
Disclosure

SEC source: 0000899243-19-017621 · doc4.xml · derivative · entry 6

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,841

Underlying: Common Stock · 3,159 shares

Expires 2028-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Read SEC document
June 19, 2019 Filed Jun 20, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock, $0.0001 par value 100 $20.81 $2,081.00
Disclosure

SEC source: 0000899243-19-017621 · doc4.xml · nonDerivative · entry 5

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,513

F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.

Read SEC document
June 19, 2019 Filed Jun 20, 2019 16:05 UTC
Viret Jean-FredericChief Financial Officer
SaleCommon Stock, $0.0001 par value 3,059 $20.32 $62,166.22
Disclosure

SEC source: 0000899243-19-017621 · doc4.xml · nonDerivative · entry 4

Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,613

F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $19.75 to $20.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.